Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets - PubMed (original) (raw)

Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets

Juan L Contreras et al. Transplantation. 2002.

Abstract

Background: Pancreatic islets are susceptible to myriad insults that occur during islet isolation and transplantation. Studies demonstrated the role of Akt in regulating pancreatic beta-cell growth and survival. Activation of Akt maintains Bad phosphorylation and prevents its binding to mitochondrial targets, decreases caspase-9 activity, and prevents the translocation of forkhead transcription factors (FKHR). Simvastatin activates Akt in mammalian cells; therefore, we investigated the role of simvastatin on human pancreatic islets (HPI) survival.

Methods: HPI were treated with simvastatin, with and without LY294002, an inhibitor of phosphoinositide 3-kinase. PI viability was examined with ethidium bromide-acridine orange, and apoptosis was examined using a quantitative assay. Akt, Bad, FKHR phosphorylation, and mitochondrial cytochrome release were analyzed by Western blots. Caspase-9 activity was assessed by a fluorometric assay. A limited number of HPI were transplanted after simvastatin treatment in diabetic NOD-SCID mice.

Results: Low levels of Akt phosphorylation (activation) were demonstrated early after islet isolation. Akt activation; increase in islet viability; and decrease in Bad phosphorylation, cytochrome release, caspase-9 activation, and translocation of FKHR were observed after simvastatin treatment, effects reversed by LY294002. Among recipients of islets without simvastatin, none demonstrated reversal of diabetes after the transplant. In contrast, 58% of the recipients given islets treated with simvastatin remained euglycemic 30 days after the transplant.

Conclusions: Targeting the survival pathway with simvastatin exerts a cytoprotective effect on isolated PI. Activation of the Akt pathway is a potential new therapeutic approach to reduce loss of functional islet mass to bolster success in clinical islet transplantation.

PubMed Disclaimer

Cited by

Amniotic Membrane Extract Protects Islets From Serum-Deprivation Induced Impairments and Improves Islet Transplantation Outcome.
Yang Z, Li X, Zhang C, Sun N, Guo T, Lin J, Li F, Zhang J. Yang Z, et al. Front Endocrinol (Lausanne). 2020 Dec 8;11:587450. doi: 10.3389/fendo.2020.587450. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33363516 Free PMC article.
Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans.
Aikin R, Rosenberg L, Paraskevas S, Maysinger D. Aikin R, et al. J Mol Med (Berl). 2004 Jun;82(6):389-97. doi: 10.1007/s00109-004-0540-5. Epub 2004 Apr 23. J Mol Med (Berl). 2004. PMID: 15105993
Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.
Barlow AD, Nicholson ML, Herbert TP. Barlow AD, et al. Diabetes. 2013 Aug;62(8):2674-82. doi: 10.2337/db13-0106. Diabetes. 2013. PMID: 23881200 Free PMC article. Review.
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2).
Barlow AD, Xie J, Moore CE, Campbell SC, Shaw JA, Nicholson ML, Herbert TP. Barlow AD, et al. Diabetologia. 2012 May;55(5):1355-65. doi: 10.1007/s00125-012-2475-7. Diabetologia. 2012. PMID: 22314813 Free PMC article.
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
Sierecki E, Sinko W, McCammon JA, Newton AC. Sierecki E, et al. J Med Chem. 2010 Oct 14;53(19):6899-911. doi: 10.1021/jm100331d. J Med Chem. 2010. PMID: 20836557 Free PMC article.

Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets - PubMed (original) (raw)